ABG-WTT Global Life Science Capital Partners GP Ltd

CIK: 0001832108Latest portfolio: $15.0M · Q4 2025

Holdings

2

Total Value

$15.0M

New Positions

0

Closed Positions

0

Top Holdings

#StockSharesValue% PortfolioChangeType
1
CBLLCERIBELL INC
441,820$9.7M64.38%-646,281
2
RPIDRAPID MICRO BIOSYSTEMS INC
1,848,296$5.4M35.62%—

Sector Breakdown

Healthcare100.0% ($96.9B)

Filing History

QuarterFiling DatePortfolio ValueHoldings
Q4 2025Feb 17, 2026$15.0M2
Q3 2025Nov 14, 2025$18.7B2
Q2 2025Aug 14, 2025$26.8B2
Q1 2025May 15, 2025$38.3B4
Q4 2024Feb 14, 2025$43.7B4

Fund Information

CIK0001832108
Most Recent FilingFeb 17, 2026
Number of Filings5
View on SEC EDGAR →

ABG-WTT Global Life Science Capital Partners GP Ltd is an institutional investment manager that files 13F reports with the SEC. As of the Q4 2025 filing, the fund reported a portfolio valued at $15.0M across 2 holdings. The largest position is CERIBELL INC (CBLL), representing 64.4% of the portfolio. Compared to the previous quarter, the fund opened 0 new positions and closed 0 positions. 13F filings are required quarterly disclosures that provide transparency into the holdings of institutional investment managers with at least $100 million in qualifying assets.